Mallinckrodt is committed to ensuring a steady, uninterrupted supply of Technetium-99m (Tc-99m) and is actively engaged in developing a stable and diverse global supply of Mo-99.
As one of the few companies in the world to reinvest in nuclear medicine, we stand at the threshold of its exciting future. As the single-most vertically integrated supplier of radiopharmaceuticals in the world, and a global leader in isotope supply communications, we remain dedicated to long-term support of the nuclear medicine community.
Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.
© 2017 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.